Current Rheumatology Reports

Papers
(The TQCC of Current Rheumatology Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Breaking Barriers: Essential Reforms for a Competitive and Affordable Biosimilars Market46
Decoding the Intricacies of Statin-Associated Muscle Symptoms44
AA Amyloidosis: A Contemporary View43
Ectopic Nociceptor Sprouting as a Key Peripheral Driver of Pain in Rheumatoid Arthritis42
Deep Insight into the Role of MIF in Spondyloarthritis41
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know36
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology30
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review28
Current perspective on infections and mitigation strategies in primary systemic vasculitis26
Treatment of Persons with Rheumatoid Arthritis with a History of Cancer25
Cardiac Manifestations in Behçet’s Syndrome25
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice24
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development23
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus22
Unveiling the Potential of Probiotics in Osteoarthritis Management21
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis21
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention20
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases20
An Update on the Diagnosis and Management of Calcium Crystal Disease19
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout19
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?19
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis19
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions18
What can Animal Models tell us About T Cells in Spondyloarthritis Pathogenesis?18
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis17
Digital Approaches for Myositis17
Spondyloarthritis Research and Treatment Network (SPARTAN) Clinical and Imaging Year in Review 202417
Newer Autoantibodies and Laboratory Assessments in Myositis17
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?16
Anti- Melanoma Differentiation-Associated Gene 5 Antibody Positive Dermatomyositis: Recent Progress in Pathophysiology and Treatment16
Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis16
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use15
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus15
An Update on Kawasaki Disease14
What to Know About Biopsy Sampling and Pathology in Vasculitis?14
Neuroimmune Mechanisms Underlying Post-acute Sequelae of SARS-CoV-2 (PASC) Pain, Predictions from a Ligand-Receptor Interactome14
Spectrum of Spondyloarthritis Among Chinese Populations14
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?14
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management14
0.046403884887695